03 April 2019 : Original article
Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
DOI: 10.12659/AOT.914101
Ann Transplant 2019; 24:175-184
HTML version available soon